School of Medicine


Showing 1-10 of 14 Results

  • Zhen Cheng

    Zhen Cheng

    Associate Professor (Research) of Radiology (General Radiology)

    Current Research and Scholarly Interests To develop novel molecular imaging probes and techniques for non-invasively early detection of cancer using multimodality imaging technologies including PET, SPECT, MRI, optical imaging, etc.

  • Frederick T. Chin, Ph.D.

    Frederick T. Chin, Ph.D.

    Assistant Professor (Research) of Radiology (General Radiology)

    Current Research and Scholarly Interests Our group's primary objectives are:

    1) Novel radioligand and radiotracer development.
    We will develop novel PET (Positron Emission Tomography) imaging agents with MIPS and Stanford faculty as well as other outside collaborations including academia and pharmaceutical industry. Although my personal research interests will be to discover and design of candidate probes that target molecular targets in the brain, our group focus will primarily be on cancer biology and gene therapy. In conjunction with our state-of-the-art imaging facility, promising candidates will be evaluated by PET-CT/MR imaging in small animals and primates. Successful radioligands and/or radiotracers will be extended towards future human clinical applications.

    2) Designing new radiolabeling techniques and methodologies.
    We will aim to design new radiolabeling techniques and methodologies that may have utility for future radiopharmaceutical development in our lab and the general radiochemistry community.

    3) Radiochemistry production of routine clinical tracers.
    Since we also have many interests with many Stanford faculty and outside collaborators, our efforts will also include the routine radiochemistry production of many existing radiotracers for human and non-human use. Our routine clinical tracers will be synthesized in custom-made or commercial synthetic modules (i.e. GE TRACERlab modules) housed in lead-shielded cells and be distributed manually or automatically (i.e. Comecer Dorothea) to our imagers.

  • Sanjiv Sam Gambhir, MD, PhD

    Sanjiv Sam Gambhir, MD, PhD

    Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research and Professor, by courtesy, of Bioengineering and of Materials Science and Engineering

    Current Research and Scholarly Interests My laboratory focuses on merging advances in molecular biology with those in biomedical imaging to advance the field of molecular imaging. Imaging for the purpose of better understanding cancer biology and applications in gene and cell therapy, as well as immunotherapy are all being studied. A key long-term focus is the earlier detection of cancer by combining in vitro diagnostics and molecular imaging.

  • Michael L. Goris

    Michael L. Goris

    Professor of Radiology (Nuclear Medicine), Emeritus

    Current Research and Scholarly Interests Radio-immunotherapy. Medical Imaging Processing. Quantification for diagnosis Clinical validations

  • Michelle L. James, PhD

    Michelle L. James, PhD

    Instructor, Radiology- Molecular Imaging Program at Stanford

    Current Research and Scholarly Interests My research is focused on developing and evaluating molecular imaging agents to improve the way we diagnose, treat, and understand brain diseases.

  • Sri-Rajasekhar (Raj) Kothapalli, PhD

    Sri-Rajasekhar (Raj) Kothapalli, PhD

    Instructor, Radiology- Molecular Imaging Program at Stanford

    Current Research and Scholarly Interests Developing novel medical devices (based on optical, ultrasound and photoacoustic technologies) and integrating them with clinically relevant molecular imaging strategies to improve the current standards in cancer/disease screening and management.

  • Shivaani Kummar, MD, FACP

    Shivaani Kummar, MD, FACP

    Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Kummar’s research interests focus on developing novel therapies for cancer. She specializes in conducting pharmacokinetic and pharmacodynamic driven first-in-human trials tailored to make early, informed decisions regarding the suitability of novel molecular agents for further clinical investigation. Her studies integrate genomics and laboratory correlates into early phase trials. She is interested in alternate trial designs to facilitate rational drug selection based on human data and help expedite drug development timelines. She has published numerous articles in medical journals and serves on a number of national and international scientific committees.

  • Craig Levin

    Craig Levin

    Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine) and, by courtesy, of Physics, of Electrical Engineering and of Bioengineering

    Current Research and Scholarly Interests Molecular Imaging Instrumentation
    Laboratory

    Our research interests involve the development of novel instrumentation and software algorithms for in vivo imaging of cellular and molecular signatures of disease in humans and small laboratory animal subjects.

  • Seung-min Park, Ph.D.

    Seung-min Park, Ph.D.

    Instructor, Radiology- Molecular Imaging Program at Stanford

    Current Research and Scholarly Interests My educational background and training have focused on creating micro- and nano-scale devices using newly-developed techniques and applying these processes to advance research in molecular/cellular biology. So far, my area of expertise has focused on developing methods to pattern, sort, and analyze biological materials, especially circulating tumor cells. Through my work I have created multiple Microelectromechanical System (MEMS) and Nanoelectromechanical System (NEMS) devices that can not only identify miniscule mass changes in microfluidics, but integrate mass spectrometry for molecular detection, and manipulate oligonucleotide species for sort and analysis. I am confident that my background provides the expertise in the design and fabrication of micro-/nano-scale functional modules necessary for developing next-generation devices in solving critical problems in biomedical engineering.